OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2018
(7)
2020
(5)
2017
(3)
2024
(1)
2022
(1)
2019
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
AKT Inhibition in Solid Tumors With AKT1 Mutations.
Not available
S-EPMC5501365
|
biostudies-literature
Cite
Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.
Not available
S-EPMC5920739
|
biostudies-literature
Cite
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Not available
S-EPMC5760397
|
biostudies-literature
Cite
Phase I pharmacological study of continuous chronomodulated capecitabine treatment.
Not available
S-EPMC7205843
|
biostudies-literature
Cite
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.
Not available
S-EPMC5728021
|
biostudies-literature
Cite
A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK.
Not available
S-EPMC5907623
|
biostudies-literature
Cite
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Not available
S-EPMC7444797
|
biostudies-literature
Cite
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors.
Not available
S-EPMC7073791
|
biostudies-literature
Cite
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With
BRAF
V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study.
Not available
S-EPMC7370699
|
biostudies-literature
Cite
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.
Not available
S-EPMC6853187
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets